Cory Deagle
Cottonwood Heights,UT
Summary
20+ years of executive product and general management leadership (SVP/GM) focused on accelerated commercial growth and P&L transformation within the healthcare technology sector. Proven partner to private equity, specializing in leveraging complex clinical data and AI/LLMs to drive financial integrity and optimizing payer financial performance across payment accuracy and quality programs.
Overview
23
23
years of professional experience
Work History
Senior Vice President and General Manager, Operations and Innovation
Machinify
09.2024 - Current
- Innovation/GM P&L & AI Platform: Currently leading all Innovation, Operations, and P&L efforts to stabilize and rapidly scale a data mining operation serving large Payers and Providers. Successfully onboarded a new leadership team and injected LLMs and advanced automation into core processes, projecting a doubling of ARR by Q4 2026.
- Corporate Development & M&A: Selected to a small, cross-functional team to execute highly confidential due diligence for major acquisitions, including the 2025 $670M Performant acquisition and the prior strategically significant 2025 Machinify acquisition.
- Strategic Product Re-Launch & M&A Commercialization: Led the strategic rebranding and clinical scope expansion of a core $40M Itemized Bill Review (IBR) product, shifting its focus from financial integrity into clinical optimization.
- September 2024 – Present | P&L: Doubling ARR by Q4 2026
Vice President Product & Strategy
Elevance/Carelon
07.2022 - 09.2024
- AI-Driven Value Growth: Instrumental in adapting and expanding an early AI practice from utilization management into Payment Integrity, driving efficiency that led to $3B in annual growth and earned recognition as an AI pioneer within the company.
- Clinical Data Platform Strategy: Led product vision to reduce clinical chart costs by 45% via strategic EMR partnership (Epic) and expanding interoperability efforts (prior authorizations), focusing on financial compliance.
- P&L Management & Turnaround (GM Role): Took ownership of the $70M Eligibility & Integrated Payments P&L. Rapidly created a three-year strategic plan that led to a 28% ARR increase (1.5% YoY historical) and a 15% lift in EBITDA margin.
- High-Stakes Stars Recovery: Led a strategic initiative focused heavily on the triple-weighted Stars diabetic quality measure, introducing key partnerships and leveraging EMR data to improve diabetic health.
- M&A Integration & Portfolio Management: Drove the integration of 15+ acquired product portfolios (valued at over $4B), rationalizing product lines, migrating customers, and ensuring retention through the successful execution of post-merger integration roadmaps.
Chief Product Officer
Arrive Health (formerly RxRevu)
07.2021 - 07.2022
- Product-Led Transformation & Commercial Impact: Partnered with the CTO and Executive Leadership to drive a company-wide cultural and operational transformation into a high-velocity, Product-Led Growth (PLG) model, restructuring the pricing and go-to-market strategy.
- Payer Revenue & EMR Integration: Developed the commercial strategy to monetize the EMR-embedded product by quantifying and validating cost-savings and adherence improvements generated by real-time pharmacy benefits, establishing the path to acquire net-new Payer revenue.
- Strategic M&A & Growth: Established the Innovation function that defined the 'build/buy' strategy, culminating in the acquisition of key Payer assets and technology from UPMC Enterprises to expand clinical workflow capabilities and drive market growth.
Vice President, Product Management & Strategy
HMS
09.2019 - 07.2021
- Successful PE Exit (Veritas Capital): Contributed to the strategic value and successful $3.4B merger/exit to Private Equity firm Veritas Capital (forming the new combined entity).
- 9x Revenue Growth & Product Turnaround: Drove 9x revenue growth for the Pharmacy Payment Integrity P&L, scaling the business from ~0.8M to $7M+ by identifying new markets and launching strategic PBM review solutions.
- M&A Integration Executive: Served as the lead product executive for the $155M Accent acquisition, successfully consolidating technology stacks, meeting all synergy targets, and generating $20M+ in client value via cross-sell efforts during year one.
- September 2019 – July 2021 | P&L Transformation & $3.4B PE Exit
Executive Leadership (VP/Director)
Cotiviti
01.2007 - 09.2019
- Successful PE Exit (Veritas Capital): Played a key role across the organization leading up to the $4.9B take-private acquisition by Veritas Capital in 2018.
- Strategic Payer Growth & Scaling: Led a multi-state operational expansion, including relocating to Salt Lake City to build a 100+ team, growing a single Payer client (Anthem) from $8M to $50M+ in annual revenue.
- P&L Management & Product Oversight: Held P&L responsibility for a $100M+ revenue budget and managed product strategy, delivery, and staffing across several healthcare payer clients.
- New Market Creation (Pharmacy Auditing): Created and launched a new Pharmacy auditing program focused on full-scope PBM plan audits for medical payers and formulary rebate reviews on behalf of pharma manufacturers, establishing a significant new revenue stream.
- January 2007 – September 2019 | P&L Management & $4.9B PE Exit
Sr. Financial Analyst
Caremark / CVS Health
01.2006 - 01.2007
- Medicare Part D Program Setup: Played an instrumental role in the financial and operational setup of the new Medicare Part D rebate program, serving as a key liaison between the PBM and pharmaceutical manufacturers.
Audit Development Manager
PRG Schultz
09.2002 - 01.2006
- International Expansion: Accepted a one-year expat assignment in Seoul, South Korea to introduce and develop recovery audit services and process improvement opportunities for an emerging, high-growth market.
Education
Post Graduate Diploma (Honors) - Applied Information Technology
Information Technology Institute (ITI)
05.2002
Bachelor of Business Administration (BBA) - Faculty of Administration
University of New Brunswick
05.2001
Skills
- COMMERCIAL & FINANCIAL LEADERSHIP
- P&L Management & Turnaround ($70M - $100M P&L Ownership)
- Private Equity (PE) Value Creation (Veritas Capital $34B / $49B exits)
- M&A Strategy & Due Diligence (Buy vs Build decisions leading to several $500M acquisitions)
- PRODUCT PLATFORM & AI STRATEGY
- Pioneering AI/LLM Strategy (Early adopter, driving organizational transformation, doubling ARR)
- Healthcare Data Platform (Claims, EMR, Auth, Pharmacy, SDOH)
- Stars Recovery & Financial Integrity (VBC optimization, payment accuracy, and financial recovery)
- EXECUTIVE & CULTURAL LEADERSHIP
- Executive Leadership & Investor Alignment (PE Focus, Board Reporting)
- High-Performance Team Scaling (Built 100 person teams, led large-scale expansion)
- Organizational & Cultural Transformation (Successful transition to PLG model)
Timeline
Senior Vice President and General Manager, Operations and Innovation
Machinify
09.2024 - Current
Vice President Product & Strategy
Elevance/Carelon
07.2022 - 09.2024
Chief Product Officer
Arrive Health (formerly RxRevu)
07.2021 - 07.2022
Vice President, Product Management & Strategy
HMS
09.2019 - 07.2021
Executive Leadership (VP/Director)
Cotiviti
01.2007 - 09.2019
Sr. Financial Analyst
Caremark / CVS Health
01.2006 - 01.2007
Audit Development Manager
PRG Schultz
09.2002 - 01.2006
Bachelor of Business Administration (BBA) - Faculty of Administration
University of New Brunswick
Post Graduate Diploma (Honors) - Applied Information Technology
Information Technology Institute (ITI)